Patient experience platform Healthera announced it has raised £2 million in strategic investment from a consortium of private and health-tech investors. This boosts the current Series A round to £5.6 million and advances Healthera’s mission to transform digital pharmacy services. This funding round was completed by private investors via the network of Committed Capital, which led the investment. Previous investors in Healthera include Cambridge Enterprise, Accelerated Digital Ventures (Legal and General), NHS England, and Innovate UK.
With a sustainable foundation set last year, the company already provides technology for over 1,700 UK pharmacies and over a million patients. Now it is prepared for significant expansion across the UK and North America and into new revenue verticals, including private medicine prescribing and the end-to-end management of clinical services.
Launched at Cambridge University, Healthera is the UK’s most popular digital pharmacy platform, connecting patients with the medicines and healthcare services they need. Last year, Healthera processed over 5 million digital prescriptions, with partners outperforming the market.
KEY QUOTES:
“This investment is a catalyst for Healthera’s next phase of growth. We’re excited to build on our UK success, deepen our technological offerings and bring our innovative solutions to the Canadian market.”
– Quintus Liu, CEO and co-founder of Healthera
“Healthera has significantly increased our prescription volume and helped us reach new patients. Their technology and personalised service are exceptional.”
– Navid Ghasemi, owner of Newport Pharmacy, a Healthera partner
“We are proud to lead this latest investment round in Healthera. Healthera has consistently demonstrated strong vision and execution in redefining digital pharmacy services, and we believe the company are uniquely positioned to lead the sector’s evolution both in the UK and internationally. We’re excited to back Quintus and the team as they continue to expand throughout the UK and support pharmacies and customers with their market leading technology.”
– Else Thomson, Investment Director at Committed Capital
